AOD 9604 Vial

AOD-9604 (Growth Hormone Fragment 177–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. It is commonly utilised in laboratory research involving peptide fragments and growth hormone-related pathways.

AOD-9604 is a modified fragment of the human growth hormone sequence, representing amino acids 177–191. In research settings, it is used as a model peptide when studying growth hormone-derived fragments and their interaction with biological systems.

Chemical reference information: CAS number: 221231-10-3; Molecular formula: C₇₈H₁₂₃N₂₃O₂₃S₂; Molecular weight: 1815.08 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

AOD 9604 5 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

221231-10-3

Molecular formula

C₇₈H₁₂₃N₂₃O₂₃S₂

Molecular weight

1815.08 g/mol

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.